Speaker: Anthony Sung, M.D.
Division of Hematologic Malignancies and Cellular Therapy
Topics: mHealth in BMT
Date: Tuesday, June 6, 2017
Time: 8:00 a.m. – 9:00 a.m.
Location: Conference Room 9015 North Pavilion
Summary of Faculty Disclosure/Planning Committee:
The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CE activity:
The following speakers and/or planning committee members have indicated they have the following relationship(s) with industry to disclose relative to the content of this CE activity: Dr. Mitchell Horwitz has indicated that he is an Advisory Board Member for Genzyme and is a Principal Investigator for both Otsuka and Pfizer. Dr. Anthony Sung is a Principal Investigator for Novartis Pharmaceutcals.
Joint Accreditation Statement
In support of improving patient care, Duke University Health System Department of Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.
Category 1*: Duke University Health System Department of Clinical Education and Professional Development designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
It is the policy of the Duke University Health System Clinical Education and Professional Development to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity.
You must text the six letter code provided by the speaker to (919)213-8033 to receive credit for attending this conference.